SF
ECYT

Synovus Financial’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Synovus Financial’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-700
Closed -$3K – 1065
2015
Q3 		$3K Hold
700
– – ﹤0.01% 914
2015
Q2 		$4K Hold
700
– – ﹤0.01% 918
2015
Q1 		$4K Buy
+700
New +$4.04K ﹤0.01% 960

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Synovus Financial's ECYT Position: Q4 2015 in Review

Synovus Financial sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2015, closing a stake of 700 shares — an estimated $3K sold.

Synovus Financial first reported a position in ECYT in Q1 2015 and held it in 3 quarters. The position peaked at $4K in Q2 2015. 102 funds tracked by Wall St. Rank hold ECYT as of Q4 2015.

  • Synovus Financial reported no remaining Endocyte, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Synovus Financial sold 700 Endocyte, Inc. Common Stock shares in Q4 2015, an estimated $3K.
  • Synovus Financial first reported a position in Endocyte, Inc. Common Stock in Q1 2015 and held it in 3 quarters.
  • Synovus Financial's Endocyte, Inc. Common Stock position peaked at $4K in Q2 2015.
  • 102 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2015.

Based on Synovus Financial's 13F filing for Q4 2015, filed 8 Feb 2016.